Description

Ceftobiprole CAS NO 209467-52-7 is a fifth-generation, broad-spectrum cephalosporin antibiotic belonging to the class of anti-MRSA β-lactams. It is valued for its potent activity against a wide range of Gram-positive bacteria, including methicillin-resistant *Staphylococcus aureus* (MRSA), and many Gram-negative pathogens. This makes it a critical active pharmaceutical ingredient (API) for the development of advanced therapeutic formulations targeting serious skin and soft tissue infections, as well as community-acquired pneumonia. Pharmaceutical manufacturers and research institutions globally rely on high-purity Ceftobiprole for drug development and production.

Application

• Pharmaceutical API: Primary use as the active ingredient in injectable antibiotic formulations.
• Anti-MRSA Therapeutics: Development of drugs specifically targeting methicillin-resistant *Staphylococcus aureus* infections.
• Hospital-Acquired Infection Treatment: Formulation of medications for complicated skin and skin structure infections (cSSSI).
• Community-Acquired Pneumonia (CAP) Treatment: Research and production of antibiotics for respiratory tract infections.
• Reference Standard: Serves as a high-purity analytical standard for quality control and regulatory testing in laboratories.
• Biomedical Research: Used in microbiological and pharmacological studies to investigate bacterial resistance mechanisms and new treatment modalities.

Basic Information

Product Name	Ceftobiprole
CAS No.	209467-52-7
Molecular Formula	C20H22N8O6S2
Molecular Weight	534.57 g/mol
Synonyms	Ceftobiprole Medocaril; BAL-5788; RO-65-5788; Ceftobiprole Medocaril Sodium; (6R,7R)-7-[(2Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetamido]-3-[(3R,4R)-4-[(3-carbamoylpyridin-1-ium-1-yl)methyl]-4-methylpyrrolidin-1-ium-1-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Zevtera; Mabelio
EINECS	Contact for details

Quality Control

Our Ceftobiprole is manufactured under strict quality systems to ensure it meets the stringent requirements for pharmaceutical active ingredients. Each batch is subjected to comprehensive analytical testing, including identification, purity assay, and impurity profiling via HPLC, in compliance with current industry and pharmacopeial standards (e.g., ICH guidelines). A Certificate of Analysis (COA) detailing all test results is provided with every shipment to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider conditions under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference standard
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Microbial Limits	Conforms to EP/USP requirements

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.